[Skip to Content]

Upstate Active Clinical Trials

Study Title:

AFT-46 CHIO3 Trial: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Upstate Institutional Review Board (IRB) Number:

1648431

Study/Protocol ID:

AFT-46

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Stephen L Graziano, MD

What is involved if I participate?

  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No

Where will the study take place?

Cancer Center
Oneida
Oswego
The Hill- radiation only

ClinicalTrials.Gov ID:

NCT04062708

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Eunice B Awuah, PhD
Phone: 315-464-5934
Email: awuahe@upstate.edu

Return to Previous Page || Search Again

Top